Fiche du document
6 mai 2020
- doi: 10.53738/REVMED.2020.16.692.0917
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.692.0917
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32374537
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_88A8DA997C5D5
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Pneumonitis Lungs--InflammationCiter ce document
E. Tadini et al., « SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.692.0917
Métriques
Partage / Export
Résumé
Since its emergence in December 2019, scientific knowledge about the SARS-CoV-2 virus has evolved rapidly but, due to the complexity and novelty of this infection and its political and economic stakes, much remains to be clarified. Thousands of studies have already been published and scientific research is constantly evolving. In this multitude of information, we offer an update of the knowledge currently available. A limitation of the propagation, the understanding of the functioning of the virus and its clinical manifestations, the administration of specific treatments, rapid and reliable diagnostic tools are the basis of the fight against this germ, which is still little known today.